Results 221 to 230 of about 10,001 (276)

Terlipressin in the management of liver disease

Expert Opinion on Pharmacotherapy, 2023
Introduction Terlipressin is a synthetic vasopressin analog which has been recently approved in the United States by the Food and Drug Administration for the treatment of hepatorenal syndrome.
Andrew R. Scheinberg, Paul L. Martin, Joshua A. Turkeltaub   +2 more
semanticscholar   +1 more source

TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW

Shock, 2023
Objective: The objective of this study was to provide an in-depth analysis of the advantages and potential research directions concerning the utilization of terlipressin (TP) in combination with norepinephrine (NE) for the management of septic shock ...
Fengkai Mao, D. Liang, Zewen Tang, Yuxuan Xu, Leqing Lin   +4 more
semanticscholar   +1 more source

A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage

American Journal of Gastroenterology
INTRODUCTION: This trial was to shorten the duration of both vasoconstrictors and prophylactic antibiotics to only 2 days in the therapy of acute gastroesophageal variceal hemorrhage.
Gin-Ho Lo, J. Yeh, Cheng-Hao Tseng, Tzu‐Haw Chen, Chi-Ming Tai, Wen-Lun Wang, Hui-Chen Lin   +6 more
semanticscholar   +1 more source

Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)

Expert Review of Gastroenterology & Hepatology, 2023
Introduction Kidney is the most common extra-hepatic organ involved in patients with advanced liver cirrhosis and acute-on-chronic liver failure.
Anand V. Kulkarni, Jason Lee, K. R. Reddy   +2 more
semanticscholar   +1 more source

From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.

Hepatology
Hepatorenal syndrome (HRS) is a rare and highly morbid form of kidney injury unique to patients with decompensated cirrhosis. HRS is a physiologic consequence of portal hypertension, leading to a functional kidney injury that can be reversed by restoring
A. Allegretti, Kavish R. Patidar, Ann T. Ma, Giuseppe Cullaro   +3 more
semanticscholar   +1 more source

Management of hepatic hydropericardium with open drainage, maximal medical therapy and terlipressin

BMJ Case Reports
We present the case of a woman in her 60s with Child-Pugh C cirrhosis who developed pericardial tamponade during an admission for a haemothorax secondary to a mechanical fall.
Tai Ermongkonchai, Phil Ha, Janine French   +2 more
semanticscholar   +1 more source

Terlipressin for hepatorenal syndrome

Current Opinion in Gastroenterology
Purpose of review The definition and diagnostic criteria of hepatorenal syndrome-acute kidney injury (HRS-AKI) has undergone recent changes. A major vasoconstrictor, terlipressin, has recently been approved as pharmacotherapy for HRS-AKI in the United ...
Florence Wong
semanticscholar   +1 more source

A Review of Terlipressin in Hepatorenal Syndrome: Targeting Endothelial Dysfunction and Subsequent Cardiovascular Adverse Events.

Cardiology in Review
Hepatorenal syndrome (HRS) is a serious complication of decompensated liver cirrhosis that results in acute kidney injury (AKI). The mortality rate is high. Endothelial dysfunction secondary to liver cirrhosis is a key driver of the development of portal
Adrienne M. Bielawski, William H. Frishman   +1 more
semanticscholar   +1 more source

Terlipressin

Reactions Weekly, 2021
  +4 more sources

Terlipressin Acetate

American Journal of Health-System Pharmacy, 2022
openaire   +2 more sources